Asthma in the Elderly

  • Charles E. Reed
Part of the Allergy Frontiers book series (ALLERGY, volume 5)

Despite the similarity of national and international guidelines for diagnosis and treatment of all ages, asthma in the elderly is a very different problem than asthma in children or younger adults. Diagnosis in this age group is particularly difficult because elderly patients frequently have coexisting lung diseases that contribute to the development of irreversible airway obstruction. Treatment is more difficult because of adverse effects of medications, especially on the heart. And death from asthma and other complicating lung diseases increases with age.

There are three kinds of questions about asthma in the elderly: WHAT? HOW? and WHY? WHAT? questions are about epidemiology: What is the frequency, age of onset, death rate? HOW? questions are about the diagnosis and treatment: How do we diagnose and treat asthma in the elderly? WHY? questions are about pathogenesis: Why is the airway obstruction incompletely reversible in so many elderly patients? Why do they develop it when they do? Why do older individuals more often develop asthma that is intrinsic rather than allergic? Why in severe asthma are some segmental bronchi completely occluded with mucus plugs? The WHAT and HOW questions have been reasonably well answered [1– 5]. Some answers to the WHY questions may be found in the innate immune response to agents from the environment.


Airway Remodel Churg Strauss Syndrome Allergic Bronchopulmonary Aspergillosis Intrinsic Asthma Late Onset Asthma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    National Asthma Education and Prevention Program Coordinating Committee (1996) Considerations for diagnosing and managing asthma in the elderly. Publication No. 96-3662Google Scholar
  2. 2.
    Barbee RA, Bloom JW (Eds) (1997) Asthma in the Elderly. Marcel Dekker, New YorkGoogle Scholar
  3. 3.
    Barbee RA, Murphy S (1998) The natural history of asthma. J. Allergy Clin. Immunol. 102:S65–S72CrossRefPubMedGoogle Scholar
  4. 4.
    Reed CE (1999) The natural history of asthma in adults: the problem of irreversibility. J. Allergy Clin. Immunol. 103:539–547CrossRefPubMedGoogle Scholar
  5. 5.
    Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'Byrne P, Sheffer A (2007) GINA guidelines on asthma and beyond. Allergy 62:102–112PubMedGoogle Scholar
  6. 6.
    Banerjee DK, Lee GS, Malik SK, Daly S (1987) Underdiagnosis of asthma in the elderly. Brit. J. Dis. Chest 81:23–29CrossRefPubMedGoogle Scholar
  7. 7.
    Sluiter HJ, Koeter GH, de Monchy JG, Postma DS, de Vries K, Orie NG (1991) The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur. Respir. J. 4:479–489PubMedGoogle Scholar
  8. 8.
    Sebastian A, Pehrson C, Larsson L (2006) Elevated concentrations of endotoxin in indoor air due to cigarette smoking. J. Environ. Monit. 8:519–522CrossRefPubMedGoogle Scholar
  9. 9.
    Bauer BA, Reed CE, Yunginger JW, Wollan PC, Silverstein MD (1997) Incidence and outcomes of asthma in the elderly. A population-based study in Rochester, Minnesota. Chest 111:303–310CrossRefPubMedGoogle Scholar
  10. 10.
    Ariano R, Panzani RC, Augeri G (1998) Late onset asthma clinical and immunological data: importance of allergy. J. Invest. Allergol. Clin. Immunol. 8:35–41Google Scholar
  11. 11.
    Braman SS, Kaemmerlen JT, Davis M (1991) Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease. Am. Rev. Respir. Dis 143:336–340Google Scholar
  12. 12.
    Dow, Coggon D, Campbell MJ, Osmond C, Holgate ST (1992) The interaction between immunoglobulin E and smoking in airflow obstruction in the elderly. Am. Rev. Respir. Dis. 146:402–407PubMedGoogle Scholar
  13. 13.
    Tracey M, Villar A, Dow L, Coggon D, Lampe FC, Holgate ST (1995) The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly. Am. J. Crit. Care Med. 151:656–662Google Scholar
  14. 14.
    Park JH, Cox-Ganser J, Rao C, Kreiss K (2006) Fungal and endotoxin measurements in dust associated with respiratory symptoms in a water-damaged office building. Indoor Air 16:192–203CrossRefPubMedGoogle Scholar
  15. 15.
    Bornehag CG, Sundell J, Hagerhed-Engman L, Sigsggard T, Janson S, Aberg N (2005) ‘Dampness’ at home and its association with airway, nose, and skin symptoms among 10,851 preschool children in Sweden: a cross-sectional study. Indoor Air 15 Suppl 10:48–55CrossRefGoogle Scholar
  16. 16.
    Burrows B, Lebowitz MD, Barbee RA, Cline MG (1991) Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population sample. J. Allergy Clinl. Immunol. 88:870–877CrossRefGoogle Scholar
  17. 17.
    Reed CE (1999) The natural history of asthma in adults: the problem of irreversibility. J. Allergy Clin. Immunol. 103:539–547CrossRefPubMedGoogle Scholar
  18. 18.
    Barbee RA (1987) The epidemiology of asthma. Monogr. Allergy 21:21–41PubMedGoogle Scholar
  19. 19.
    Yunginger JW, Reed CE, O'Connell EJ, Melton LJ III, O'Fallon WM, Silverstein MD (1992) A community-based study of the epidemiology of asthma. Incidence rates, 1964–1983. Am. Rev. Respir. Dis. 146:888–894PubMedGoogle Scholar
  20. 20.
    Reed, CE (2006) The natural history of asthma. J. Allergy Clin. Immunol. 118:543–548CrossRefPubMedGoogle Scholar
  21. 21.
    Silverstein MD, Reed CE, O'Connell EJ, Melton LJ III, O'Fallon WM, Yunginger, JW (1994) Long-term survival of a cohort of community residents with asthma. N. Engl. J. Med. 331:1537–1541CrossRefPubMedGoogle Scholar
  22. 22.
    Capewell S (1993) Asthma in Scotland: epidemiology and clinical management. Health Bull. 51:118–127Google Scholar
  23. 23.
    Hunt LW Jr, Silverstein MD, Reed CE, O'Connell EJ, O'Fallon WM, Yunginger JW (1993) Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA 269:1947–1952CrossRefPubMedGoogle Scholar
  24. 24.
    McCoy L, Redelings M, Sorvillo F, Simon P (2005) A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001. J. Asthma 42:757–763CrossRefPubMedGoogle Scholar
  25. 25.
    Cluroe AD, Beasley R, Lorimer S, Holloway L (1994) The relationship between pulmonary interstitial emphysema and clinical features in fatal asthma. J. Asthma 31:65–69CrossRefPubMedGoogle Scholar
  26. 26.
    Bremner P, Burgess CD, Crane J, McHaffie D, Galletly D, Pearce N, Woodman K, Beasley R (1992) Cardiovascular effects of fenoterol under conditions of hypoxaemia. Thorax 47:814–817CrossRefPubMedGoogle Scholar
  27. 27.
    Martinez FD (2006) Serious adverse events and death associated with treatment using long-acting beta-agonists. Clin. Rev. Allergy Immunol. 31:269–278CrossRefPubMedGoogle Scholar
  28. 27a.
    Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ (1995) Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Resp Crit Care Med 151:1907–14PubMedGoogle Scholar
  29. 28.
    Brown DW, Young KE, Anda RF, Giles WH (2005) Asthma and risk of death from lung cancer: NHANES II Mortality Study. J. Asthma 42:597–600CrossRefPubMedGoogle Scholar
  30. 29.
    Fish JE, Peters SP (1999) Airway remodeling and persistent airway obstruction in asthma. J. Allergy Clin. Immunol. 104:509–516CrossRefPubMedGoogle Scholar
  31. 30.
    Dompeling E, van Schayck CP, van Grunsven PM, van Herwaarden CL, Akkermans R, Molema J, Folgering H, van Weel C (1993) Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann. Intern. Med. 118:770–778PubMedGoogle Scholar
  32. 31.
    Yilmaz S, Ekici A, Ekici M, Keles H (2006) High-resolution computed tomography findings in elderly patients with asthma. Eur. J. Radiol. 59:238–243CrossRefPubMedGoogle Scholar
  33. 32.
    Greenberger PA (2002) Allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 110:685–692CrossRefPubMedGoogle Scholar
  34. 33.
    Paganin F, Seneterre E, Chanez P, Daures JP, Bruel JM, Michel FB, Bousquet J (1996) Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am. J. Respir. Crit. Care Med. 153:110–114PubMedGoogle Scholar
  35. 34.
    Simpson JC, Niven RM, Pickering CA, Fletcher AM, Oldham LA, Francis HM (1998) Prevalence and predictors of work related respiratory symptoms in workers exposed to organic dusts. Occup. Environ. Med. 55:668–672CrossRefPubMedGoogle Scholar
  36. 35.
    Reed CE, Milton DK (2001) Endotoxin-stimulated innate immunity: A contributing factor for asthma. J. Allergy Clin. Immunol. 108:157–166CrossRefPubMedGoogle Scholar
  37. 36.
    Park JH, Spiegelman DL, Gold DR, Burge HA, Milton DK (2001) Predictors of airborne endotoxin in the home. Environ. Health Perspect. 109:859–864CrossRefPubMedGoogle Scholar
  38. 37.
    Prados M, Monteseirin FJ, Carranco MI, Aragon R, Conde A, Conde (1995) Phenotypes of alpha-1-antitrypsin in intrinsic asthma and ASA-triad patients. Allergol et Immunopathol. 23:24–28Google Scholar
  39. 38.
    Martinez FD (2007) Gene-environment interactions in asthma: with apologies to William of Ockham. Proc. Am. Thorac. Soc. 4:26–31CrossRefPubMedGoogle Scholar
  40. 39.
    Bjornsson E, Norback D, Janson C, Widstrom J, Palmgren U, Strom G, Boman G (1995) Asthmatic symptoms and indoor levels of micro-organisms and house dust mites. Clin. Exp. Allergy 25:423–431CrossRefPubMedGoogle Scholar
  41. 40.
    Etzel R, Rylander R (1999) Indoor mold and children's health. Environ. Health Perspect. 107 Suppl 3:463Google Scholar
  42. 41.
    Dangman KH, Bracker AL, Storey E (2005) Work-related asthma in teachers in Connecticut: association with chronic water damage and fungal growth in schools. Conn. Med. 69:9–17PubMedGoogle Scholar
  43. 42.
    Rao CY, Riggs MA, Chew GL, Muilenberg ML, Thorne PS, Van Sickle D, Dunn KH, Brown C (2007) Characterization of airborne molds, endotoxins, and glucans in homes in New Orleans after Hurricanes Katrina and Rita. Appl. Environ. Microbiol. 73:1630–1634CrossRefPubMedGoogle Scholar
  44. 43.
    Jaakkola MS, Nordman H, Piipari R, Uitti J, Laitinen J, Karjalainen A, Hahtola P, Jaakkola JJ (2002) Indoor dampness and molds and development of adult-onset asthma: a population-based incident case-control study. Environ. Health Perspect. 110:543–547PubMedGoogle Scholar
  45. 44.
    Reed CE, Kita H (2004) The role of protease activation of inflammation in allergic respiratory diseases. J. Allergy Clin. Immunol. 114:997–1008CrossRefPubMedGoogle Scholar
  46. 45.
    Gough L, Campbell E, Bayley D, Van Heeke G, Shakib F (2003) Proteolytic activity of the house dust mite allergen Der p 1 enhances allergenicity in a mouse inhalation model. Clin. Exp. Allergy 33:1159–1163CrossRefPubMedGoogle Scholar
  47. 46.
    Kheradmand F, Kiss A, Xu J, Lee SH, Kolattukudy PE, Corry DB (2002) A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169:5904–5911PubMedGoogle Scholar
  48. 47.
    Donnelly S, Dalton JP, Loukas A (2006) Proteases in helminth- and allergen-induced inflammatory responses. Chem. Immunol. Allergy 90:45–64CrossRefPubMedGoogle Scholar
  49. 48.
    Pollock KG, McNeil KS, Mottram JC, Lyons RE, Brewer JM, Scott P, Coombs GH, Alexander J (2003) The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J. Immunol. 170:1746–1753PubMedGoogle Scholar
  50. 49.
    Miike S, Kita H (2003) Human eosinophils are activated by cysteine proteases and release inflammatory mediators. J. Allergy Clin. Immunol. 111:704–713CrossRefPubMedGoogle Scholar
  51. 50.
    Tomee JF, van Weissenbruch R, De Monchy JG, Kauffman HF (1998) Interactions between inhalant allergen extracts and airway epithelial cells: effect on cytokine production and cell detachment. J. Allergy Clin. Immunol. 102:75–85CrossRefPubMedGoogle Scholar
  52. 51.
    Iraneta SG, Duschak VG, Rodriguez SM, Seoane MA, Albonico JF, Alonso A (1999) Proteinase and gelatinolytic activities of house dust mite and cockroach extracts. J. Investig. Allergol. Clin. Immunol 9:235–240PubMedGoogle Scholar
  53. 52.
    Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, Roberts GD (1999) The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin. Proc. 74:877–884CrossRefPubMedGoogle Scholar
  54. 53.
    Taylor MJ, Ponikau JU, Sherris DA, Kern EB, Gaffey TA, Kephart G, Kita H (2002) Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol. Head Neck Surg. 127:377–383CrossRefPubMedGoogle Scholar
  55. 54.
    Wei JL, Kita H, Sherris DA, Kern EB, Weaver A, Ponikau JU (2003) The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis. Laryngoscope 113:303–306CrossRefPubMedGoogle Scholar
  56. 55.
    Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H (2005) Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J. Immunol. 175:5439–5447PubMedGoogle Scholar
  57. 56.
    Borger P, Koeter GH, Timmerman JA, Vellenga E, Tomee JF, Kauffman HF (1999) Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J. Infect. Dis. 180:1267–1274CrossRefPubMedGoogle Scholar
  58. 57.
    Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P (2000) Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J. Allergy Clin. Immunol. 105:1185–1193CrossRefPubMedGoogle Scholar
  59. 58.
    Knight DA, Lim S, Scaffidi AK, Roche N, Chung KF, Stewart GA, Thompson PJ (2001) Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma. J. Allergy Clin. Immunol. 108:797–803CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2009

Authors and Affiliations

  • Charles E. Reed
    • 1
  1. 1.Mayo Medical SchoolRochesterUSA

Personalised recommendations